Acerta Pharma Competitors and Similar CompaniesClear all

Acerta Pharma's competitors and similar companies include Calithera Biosciences, Verastem Oncology, Ablynx and Amolyt Pharma.
Acerta Pharma
Acerta Pharma
Acerta Pharma is a biopharmaceutical company.
Calithera Biosciences
Calithera Biosciences
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Verastem Oncology
Verastem Oncology
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
Ablynx
Ablynx
Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.
Amolyt Pharma
Amolyt Pharma
Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.
Founding Date
Founding Date
2013
Founding Date
2010
Founding Date
2010
Founding Date
2001
Founding Date
2015
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Subsidiary
Type
Subsidiary
Tags
Locations
Locations
South San Francisco, US HQ
Oss, NL
Oss, NL
Locations
South San Francisco, US HQ
Locations
Needham, US HQ
Walsrode, DE
Locations
Gent, BE HQ
Locations
Écully, FR HQ
Cambridge, US
Employees
Employees
197
Employees
798% increase
Employees
5719% increase
Employees
1881% decrease
Employees
605% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
122.1 k
Valuation ($)
298.7 m
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
2.6 k
Twitter followers
284
Twitter followers
166
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
2
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
4
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%

Financial

Net income
Net income
N/A
Net income
($39.7m) (FY, 2022)
Net income
($87.4m) (FY, 2023)
Net income
(€1.1m) (FY, 2016)
Net income
N/A

Operating

Phase I/II Trials Products
Phase I/II Trials Products
N/A
Phase I/II Trials Products
1 (FY, 2016)
Phase I/II Trials Products
6 (FY, 2020)
Phase I/II Trials Products
N/A
Phase I/II Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 60m
Total funding raised
$ 105m
Total funding raised
$ 170m
Total funding raised
$ 498.8m
Total funding raised
$ 93.1m
For sources of this data, please see the company profile

View Company Profiles

Calithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase

Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.

View company
Verastem Oncology
HQ
Needham, US
Employees
57↑ 19% increase

Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.

View company
Ablynx
HQ
Gent, BE

Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments.

View company
Amolyt Pharma
HQ
Écully, FR

Amolyt Pharma (formerly known as Alizé Pharma) is a company that specializes in the development of biopharmaceutical drugs, proteins, and peptides for the treatment of metabolic diseases and cancer.

View company